INAHTA

New publications

Paracetamol and Ibuprofen for the Treatment of Fever in Children: The PITCH Randomized Controlled Trial (INAHTA Briefs)
Development of a Decision Support Tool for Primary Care Management of Patients with Abnormal Liver Function Tests Without Clinically Apparent Liver Disease: A Record-Linkage Population Cohort Study and Decision Analysis (ALFIE) (INAHTA Briefs)
Diagnostic Strategies Using DNA Testing for Hereditary Hemochromatosis in At-Risk Populations: A Systematic Review and Economic Evaluation (INAHTA Briefs)
Randomized Controlled Trial to Determine the Clinical and Cost Effectiveness of Selective Serotonin Reuptake Inhibitors Plus Supportive Care, Versus Supportive Care Alone, for Mild to Moderate Depression with Somatic Symptoms in Primary Care. (INAHTA Briefs)
Neuroleptics in the Treatment of Aggressive Challenging Behavior for People with Intellectual Disabilities: A Randomized Controlled Trial (NACHBID) (INAHTA Briefs)
Systematic Review of Respite Care in the Frail Elderly (INAHTA Briefs)

About INAHTA

INAHTA (International Network of Agencies for Health Technology Assessment) a non-profit organization was established in 1993 and has now grown to 46 member agencies from 26 countries including North and Latin America, Europe, Asia, Australia, and New Zealand. All members are non-profit making organizations producing HTA and are linked to regional or national government.

Many organizations throughout the world assess healthcare technology. There is an evident need to cooperate and share information from different cultures. INAHTA serves this purpose. The Secretariat is located at SBU in Sweden.

Mission

INAHTA´s mission is to provide a forum for the identification and pursuit of interests common to HTA agencies. The network aims to:

Accelerate exchange and collaboration among agencies